Clinical Trial Update: A Multiple Ascending Dose Study of R1507 in Children and Adolescents With Advanced Solid Tumors. [Phase 1]

View source ↗

Summary

Roche's investigational antibody R1507 was studied in a phase 1 multiple ascending dose trial in children and adolescents with advanced solid tumors; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• R1507

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Neoplasms | Phase 1 | Status: COMPLETED